OBJECTIVE: The objective of this study was to evaluate the characteristics of bloodstream infections occurring among outpatients having recent contact with the health care system compared to hospital and community-acquired infections. METHODS: Prospective observational cohort study of adult patients with bloodstream infections at three teaching hospitals. Bloodstream infection was defined as hospital-acquired if the first positive blood culture was performed more than 48 h after admission. Other bloodstream infections were classified as healthcare-associated or community-acquired. RESULTS: A total of 1157 episodes of bloodstream infections were studied; 581 (50.2%) were community-acquired, 295 (25.5%) were hospital-acquired, and 281 (24.3%) were health care-associated. Of the 281 health care-associated bloodstream infections, 68 (24%) occurred in patients residing in a nursing home, 104 (37%) in patients receiving intravenous therapy, health care at home, chemotherapy or attending dialysis, and 169 (60%) in patients hospitalized during the 90 days before their bloodstream infection (some patients belonged to more than one risk category). The highest prevalence rate of MRSA infections occurred in healthcare-associated infections (5%) (p<0.001). A significantly higher mortality rate was seen in the group with healthcare-associated infections (27.5%) than in community-acquired infections (10.4%) (p<0.001). CONCLUSIONS: Our results confirm that healthcare-associated bloodstream infections show important differences from community-acquired bloodstream infections and suggest that empirical antibiotic therapy should be similar to hospital-acquired bloodstream infections, taking into account the epidemiologic characteristics of each region.
OBJECTIVE: The objective of this study was to evaluate the characteristics of bloodstream infections occurring among outpatients having recent contact with the health care system compared to hospital and community-acquired infections. METHODS: Prospective observational cohort study of adult patients with bloodstream infections at three teaching hospitals. Bloodstream infection was defined as hospital-acquired if the first positive blood culture was performed more than 48 h after admission. Other bloodstream infections were classified as healthcare-associated or community-acquired. RESULTS: A total of 1157 episodes of bloodstream infections were studied; 581 (50.2%) were community-acquired, 295 (25.5%) were hospital-acquired, and 281 (24.3%) were health care-associated. Of the 281 health care-associated bloodstream infections, 68 (24%) occurred in patients residing in a nursing home, 104 (37%) in patients receiving intravenous therapy, health care at home, chemotherapy or attending dialysis, and 169 (60%) in patients hospitalized during the 90 days before their bloodstream infection (some patients belonged to more than one risk category). The highest prevalence rate of MRSA infections occurred in healthcare-associated infections (5%) (p<0.001). A significantly higher mortality rate was seen in the group with healthcare-associated infections (27.5%) than in community-acquired infections (10.4%) (p<0.001). CONCLUSIONS: Our results confirm that healthcare-associated bloodstream infections show important differences from community-acquired bloodstream infections and suggest that empirical antibiotic therapy should be similar to hospital-acquired bloodstream infections, taking into account the epidemiologic characteristics of each region.
Authors: Elisabeth Broex; Boudewijn Catry; Katrien Latour; Karl Mertens; Vanessa Vankerckhoven; Arno Muller; Rudi Stroobants; Peter Zarb; Herman Goossens; Béatrice Jans Journal: Drugs Aging Date: 2011-10-01 Impact factor: 3.923
Authors: C Hernandez; N Cobos-Trigueros; C Feher; L Morata; C De La Calle; F Marco; M Almela; A Soriano; J Mensa; A Del Rio; J A Martinez Journal: Eur J Clin Microbiol Infect Dis Date: 2014-06-08 Impact factor: 3.267
Authors: Yang Hyun Cho; Seung Il Jung; Ho Suck Chung; Ho Song Yu; Eu Chang Hwang; Sun-Ouck Kim; Taek Won Kang; Dong Deuk Kwon; Kwangsung Park Journal: Int Urol Nephrol Date: 2015-05-31 Impact factor: 2.370
Authors: Angela Hattemer; Alan Hauser; Maureen Diaz; Marc Scheetz; Nirav Shah; Jonathan P Allen; Jahan Porhomayon; Ali A El-Solh Journal: Antimicrob Agents Chemother Date: 2013-06-03 Impact factor: 5.191
Authors: Natividad Benito; José M Miró; Elisa de Lazzari; Christopher H Cabell; Ana del Río; Javier Altclas; Patrick Commerford; Francois Delahaye; Stefan Dragulescu; Helen Giamarellou; Gilbert Habib; Adeeba Kamarulzaman; A Sampath Kumar; Francisco M Nacinovich; Fredy Suter; Christophe Tribouilloy; Krishnan Venugopal; Asuncion Moreno; Vance G Fowler Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391